Theriva Biologics Statistics
Total Valuation
TOVX has a market cap or net worth of $7.05 million. The enterprise value is -$14.08 million.
| Market Cap | 7.05M |
| Enterprise Value | -14.08M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TOVX has 17.15 million shares outstanding. The number of shares has increased by 5.09% in one year.
| Shares Outstanding | 17.15M |
| Shares Change (YoY) | +5.09% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 6.14% |
| Float | 16.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.07 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.90% and return on invested capital (ROIC) is -54.79%.
| Return on Equity (ROE) | -42.90% |
| Return on Assets (ROA) | -29.30% |
| Return on Capital (ROIC) | -54.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$834,045 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.56% in the last 52 weeks. The beta is 1.47, so TOVX's price volatility has been higher than the market average.
| Beta (1Y) | 1.47 |
| 52-Week Price Change | -39.56% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (30 Days) | 99,390 |
Short Selling Information
The latest short interest is 411,008, so 2.40% of the outstanding shares have been sold short.
| Short Interest | 411,008 |
| Short Previous Month | 348,186 |
| Short % of Shares Out | 2.40% |
| Short % of Float | 2.44% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.43M |
| Pretax Income | -19.99M |
| Net Income | -18.35M |
| EBITDA | -19.47M |
| EBIT | -19.99M |
| Earnings Per Share (EPS) | -$1.14 |
Balance Sheet
The company has $23.28 million in cash and $2.15 million in debt, giving a net cash position of $21.13 million or $1.23 per share.
| Cash & Cash Equivalents | 23.28M |
| Total Debt | 2.15M |
| Net Cash | 21.13M |
| Net Cash Per Share | $1.23 |
| Equity / Book Value | 36.96M |
| Book Value Per Share | 2.16 |
| Working Capital | 20.67M |
Cash Flow
In the last 12 months, operating cash flow was -$19.00 million and capital expenditures -$202,000, giving a free cash flow of -$19.20 million.
| Operating Cash Flow | -19.00M |
| Capital Expenditures | -202,000 |
| Free Cash Flow | -19.20M |
| FCF Per Share | -$1.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.09% |
| Shareholder Yield | -5.09% |
| Earnings Yield | -260.35% |
| FCF Yield | -272.40% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 25, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |